METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION
South Korea
2020-7012343
Filed on 2018-09-17
2020-7012343
Filed on 2018-09-17
METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION
Japan
2020-517553
Filed on 2018-09-17
2020-517553
Filed on 2018-09-17
METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION
Israel
273516
Filed on 2018-09-17
273516
Filed on 2018-09-17
METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION
European Patent
18782605.2
Filed on 2018-09-17
18782605.2
Filed on 2018-09-17
METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION
China
201880063656.4
Filed on 2018-09-17
201880063656.4
Filed on 2018-09-17
METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION
Canada
3080274
Filed on 2018-09-17
3080274
Filed on 2018-09-17
METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION
Australia
2018342245
Filed on 2018-09-17
2018342245
Filed on 2018-09-17
METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION
US Application 16/652,948
Filed on 2020-04-01
Filed on 2020-04-01
METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION
Singapore
11202003112Q
Filed on 2018-09-24
11202003112Q
Filed on 2018-09-24